AP113
Goat Anti-Human IgG Antibody, Fc
2 mg/mL, Chemicon®
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.46
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ELISA, IP, WB
Citations:
11
biological source
goat
conjugate
unconjugated
antibody form
affinity purified immunoglobulin
antibody product type
secondary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
concentration
2 mg/mL
technique(s)
ELISA: suitable, immunoprecipitation (IP): suitable, western blot: suitable
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Related Categories
Immunogen
Human IgG, Fc
Application
Optimal working dilutions must be determined by end user.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Fragment Specific Secondary Antibodies
Fragment Specific Secondary Antibodies
This Goat anti-Human IgG Antibody, Fc is validated for use in ELISA, IP, WB for the detection of Human IgG.
Biochem/physiol Actions
Shows a single band when run in an IEP system at a minimum concentration of 10 mg/mL, using human whole serum as the antigen. Based on immunoselectrophoresis, the antibody reacts with the heavy chains on human IgG but not with the light chains on most human immunoglobulins. No antibody was detected against human IgM or IgA, or other non-immunoglobulin serum proteins, but there may be cross reactivity with immunoglobulins from other species.
Physical form
Affinity purified immunoglobulin. Liquid in 0.02M Phosphate buffer, 0.25M Sodium Chloride with 0.1% Sodium Azide.
Preparation Note
Store at 2-8°C for up to six months. Do not freeze.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
wgk
WGK 2
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ren-You Pan et al.
Nature communications, 10(1), 3569-3569 (2019-08-10)
Drug hypersensitivity such as severe cutaneous adverse reactions (SCAR), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), could be life-threatening. Here, we enroll SCAR patients to investigate the T cell receptor (TCR) repertoire by next-generation sequencing. A public αβTCR
Katherine L Williams et al.
Nature medicine, 30(1), 117-129 (2024-01-04)
Over 75% of malaria-attributable deaths occur in children under the age of 5 years. However, the first malaria vaccine recommended by the World Health Organization (WHO) for pediatric use, RTS,S/AS01 (Mosquirix), has modest efficacy. Complementary strategies, including monoclonal antibodies, will be
Nerea Martín Almazán et al.
iScience, 26(12), 108441-108441 (2023-12-25)
Susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is highly variable and could be mediated by a cross-protective pre-immunity. We identified 14 cross-reactive peptides between SARS-CoV-2 and influenza A H1N1, H3N2, and human herpesvirus (HHV)-6A/B with potential relevance.
Tyrosine replacement of PSGL-1 reduces association kinetics with P- and L-selectin on the cell membrane.
Xiao, B; Tong, C; Jia, X; Guo, R; Lu, S; Zhang, Y; McEver, RP; Zhu, C; Long, M
Biophysical Journal null
Céline Ortega-Ferreira et al.
Nature communications, 14(1), 5291-5291 (2023-09-01)
Systemic sclerosis (SSc) is an autoimmune, inflammatory and fibrotic disease with limited treatment options. Developing new therapies is therefore crucial to address patient needs. To this end, we focused on galectin-3 (Gal-3), a lectin known to be associated with several
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service